PP01.19: Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer
Back to course
Pdf Summary
Asset Subtitle
Sonam Puri
Keywords
Tarlatamab
bispecific T-cell engager
small cell lung cancer
cytokine release syndrome
immune effector cell-associated neurotoxicity syndrome
prophylactic Tocilizumab
adverse events
real-world study
high-risk patients
treatment outcomes
Powered By